Endothelin-1 increases CHSY-1 expression in aortic endothelial cells via transactivation of transforming growth factor β type I receptor induced by type B receptor endothelin-1
- 27 February 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 71 (6) , 988-995
Abstract
Objectives TGF‐β through hyperelongation of glycosaminoglycan (GAG) chains leads to binding of low‐density lipoproteins to the proteoglycans. The vasoactive peptide, endothelin‐1 (ET‐1), plays a key role in the development of atherosclerosis. This study addressed the question whether ET‐1 by activating the Rho kinase and cytoskeletal rearrangement can transactivate the TGF‐β receptor leading to phosphorylation of the transcription factor Smad2 and increased expression of the GAG chain synthesizing enzyme such as chondroitin synthase‐1 (CHSY‐1) in bovine aortic endothelial cells (BAECs). Methods In this study, intermediates in ET‐1‐induced Smad2C phosphorylation and the protein level of CHSY‐1 were identified and quantified by Western blotting. Key findings Endothelin‐1 caused time‐dependent phosphorylation of Smad2C which was inhibited in the presence of the endothelin B receptor antagonist, BQ788. The response to ET‐1 was inhibited by the Rho/ROCK kinase antagonist, Y27632 and by cytochalasin D, an inhibitor of actin polymerization but the ET‐1‐mediated pSmad2C was not inhibited by the matrix metalloproteinase (MMP) inhibitor, GM6001. ET‐1 increased CHSY‐1 protein level, which was inhibited in the presence of BQ788, cytochalasin D and Y27632. Conclusions Endothelin‐1 signalling via the ETB receptor utilizes cytoskeletal rearrangement and Rho kinase but not MMPs leading to TβRI transactivation signalling and phosphorylation of Smad2C and through this pathway increased the level of CHSY‐1.Keywords
Funding Information
- Ahvaz Jundishapur University of Medical Sciences (U-94114)
This publication has 31 references indexed in Scilit:
- Thrombin-mediated Proteoglycan Synthesis Utilizes Both Protein-tyrosine Kinase and Serine/Threonine Kinase Receptor Transactivation in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2013
- The actin cytoskeleton as a sensor and mediator of apoptosisBioArchitecture, 2012
- Correlation of C4ST-1 and ChGn-2 expression with chondroitin sulfate chain elongation in atherosclerosisBiochemical and Biophysical Research Communications, 2011
- Rho‐kinase/ROCK: A key regulator of the cytoskeleton and cell polarityCytoskeleton, 2010
- Thrombin Stimulation of Proteoglycan Synthesis in Vascular Smooth Muscle Is Mediated by Protease-activated Receptor-1 Transactivation of the Transforming Growth Factor β Type I ReceptorJournal of Biological Chemistry, 2010
- Maintenance of adrenergic vascular tone by MMP transactivation of the EGFR requires PI3K and mitochondrial ATP synthesisCardiovascular Research, 2009
- Immune and Inflammatory Mechanisms of AtherosclerosisAnnual Review of Immunology, 2009
- Contrasting Actions of Endothelin ETAand ETBReceptors in Cardiovascular DiseaseAnnual Review of Pharmacology and Toxicology, 2007
- ET A Receptor Mediates Altered Leukocyte-Endothelial Cell Interaction and Adhesion Molecules Expression in DOCA–Salt RatsHypertension, 2004
- Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptorsNature, 1996